Go to deals
TMT | Other Industries

Miroi AB has been acquired by Via Venture Partners

The shareholders of Miroi AB, one of the leading e-learning company in adult education, have sold 70% of the company to Via Venture Partners for an undisclosed consideration.

Miroi AB is one of the leading e-learning companies in adult education and job matching. The company operates in around 60 locations in Sweden and has its head office in Luleå.

Via Venture Partners invests in companies ready to expand outside the Nordic region, but it also supports seed and early stage ventures. Although it invest in companies of all sizes, the focus is on those with revenues between US$7– 40 million.

The shareholders have retained 30% of the shares.

Oaklins' team in Sweden advised the seller in this transaction.

Parties

Talk to the deal team

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more